Last $0.41 USD
Change Today +0.053 / 14.72%
Volume 1.5K
CRXM On Other Exchanges
Symbol
Exchange
OTC US
As of 8:10 PM 09/19/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Christopher J. Reinhard

Co-Founder, Executive Chairman, Chief Executive Officer, President, Treasurer, Chief Executive Officer of Tissue Repair Company and President of Tissue Repair Company, TaxuCardium Pharmaceuticals Group Inc.
AgeTotal Calculated CompensationThis person is connected to 27 board members in 2 different organizations across 4 different industries.

See Board Relationships
60$332,817
As of Fiscal Year 2013

Background*

Mr. Christopher J. Reinhard Co-founded Cardium Therapeutics Inc. in December 2003 and has been its Executive Chairman, Chief Executive Officer, President and Treasurer since then. Mr. Reinhard has been the Chairman, President and Chief Executive Officer of Tissue Repair Company since August, 2006. Mr. Reinhard served as the Chief Executive Officer and Treasurer of Innercool Therapies, Inc. since March 2006. He served as Interim Chief Executive Officer and interim President ...

Read Full Background

Corporate Headquarters*

11750 Sorrento Valley Road
San Diego, California 92121

United States

Phone: 858-436-1000
Fax: 858-436-1001

Board Members Memberships*

1995-N/A
Co-Founder
2003-N/A
Former Chairman of the Board of Directors, Chief Executive Officer, President and Treasurer
2003-Present
Co-Founder, Executive Chairman, Chief Executive Officer, President, Treasurer, Chief Executive Officer of Tissue Repair Company and President of Tissue Repair Company
2004-N/A
Former Director
2006-Present
Chairman and Chief Executive Officer

Education*

BS
Babson College
MBA
Babson College

Other Affiliations*

Annual Compensation*

Salary$332,817
Total Annual Compensation$332,817

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$332,817
Total Short Term Compensation$332,817
Total Calculated Compensation$332,817
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CRXM:US $0.41 USD +0.053

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CARDIUM THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.